The PTPN22 R620W polymorphism - Effects on susceptibility and clinical features on British Caucasian rheumatoid arthritis patients.
Main Authors: | Harrison, P, Pointon, J, Farrar, C, Wordsworth, P, Brown, M |
---|---|
Format: | Conference item |
Published: |
2005
|
Similar Items
-
Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
by: Harrison, P, et al.
Published: (2006) -
Effects of interleukin-1 polymorphisms on susceptibility and clinical characteristics of British caucasian rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2008) -
MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
by: Harrison, P, et al.
Published: (2007) -
HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2006) -
The PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp.
by: Wan R Wan Taib, et al.
Published: (2010-10-01)